Aptamers Market
                     Title:
Aptamers Market Size Worth USD 342 million by 2026| CAGR: 17.7%: MarketsandMarkets™
Keywords:
Aptamers Market, Aptamers Market Size, Aptamers industry Share, Aptamers Market Growth, 
Aptamers Market Trends, Aptamers Market outlook, Aptamers Market Forecast, Aptamers Market 
Demand
Content:
According to the new market research report "Aptamers Market by Product Type (DNA, RNA, XNA), 
Technology (SELEX), Application (Therapeutics, Diagnostics, R&D), End Users (Pharmaceutical & 
Biotechnology Companies, Academic & Government Research Institutes, CROs) - Global Forecast to 
2026", published by MarketsandMarkets™, the global market was valued at an estimated USD 151 
million in 2021 and is projected to reach USD 342 million by 2026, at a CAGR of 17.7% during the 
forecast period.
Key Players:
Aptamer Group (UK), Raptamer Discovery Group (US), SomaLogic Inc. (US), Aptamer Sciences, Inc. 
(South Korea) and Aptagen, LLC (US).
Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1167
Browse in-depth TOC on "Aptamers Industry"
196 – Tables
38 – Figures
183 – Pages
Growth of aptamers market is attributed to factors such as increase in number of clinical trials for 
development of aptamer-based therapeutics, increase in awareness about advantages of aptamers 
as compared to antibodies, rising investment in pharmaceutical R&D, and rising prevalence of 
chronic and rare diseases to increase the demand for aptamer-based therapeutics and diagnostics.
Growth in the venture capital funding for research on aptamers and growing collaborations with 
research institutes and pharmaceutical companies are also expected to offer a wide range of growth 
opportunities to players in the market. On the other hand, low market acceptance as compared to 
antibodies is likely to restrain the market growth while shortage of skilled & trained professionals 
may challenge market growth to a certain extent.
Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1167
Lower production cost and higher stability will drive the DNA-based aptamers segment growth
Based on type, the aptamers market is segmented into DNA aptamers, XNA aptamers, and RNA 
aptamers. The DNA-based aptamers segment dominated the market in 2020. The large share of this 
segment is attributed to their lower production cost and higher stability compared to other nucleic 
acid-based aptamers and the wide availability of DNA aptamers.
Others segment is expected to witness the highest CAGR during the forecast period
Based on technology, the aptamers market is segmented into SELEX and other technologies. The 
SELEX technology segment dominated the market in 2020. The segment accounts for a large share of
the aptamers market as SELEX is one of the most widely used technologies. The other technologies 
segment is expected to register the highest CAGR during the forecast period due to the increasing 
focus on developing technologies for aptamer selection.
North America was the largest regional market for aptamers industry in 2020
The global aptamers market is segmented into five major regions, namely, North America, Europe, 
the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for 
the largest share of the market. The largest share of North America is attributed to the availability of 
funds to develop innovative technologies, the presence of prominent market players, and growing 
collaborations among companies.
Speak to Analyst: 
https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=1167
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche 
opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently 
servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. 
Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for 
their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets 
following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the
clients to identify new opportunities, identify most important customers, write "Attack, avoid and 
defend" strategies, identify sources of incremental revenues for both the company and its 
competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top 
players across leaders, emerging companies, innovators, strategic players) annually in high growth 
emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies 
this year for their revenue planning and help them take their innovations/disruptions early to the 
market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, 
"Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding 
of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: 1-888-600-6441
Email: [email protected]
Related Reports: -
Molecular Biology Enzymes Kits Reagents Market
https://www.marketsandmarkets.com/Market-Reports/molecular-biology-enzymes-kits-
reagents-market-164131709.html
Oligonucleotide Synthesis Market
https://www.marketsandmarkets.com/Market-Reports/oligonucleotide-synthesis-market-
200829350.html